Performance Evaluation Study of the reagent Total Bile Acids FS in humane stool samples

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00031283

Enrollment

200

Registered

2023-02-24

Start date

2023-02-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K50 K58 K90

Interventions

Group 1: In this monocentric, retrospective performance evaluation study, processed stool samples with the Total Bile Acids 21 FS reagent kit will be evaluated on the clinical chemistry analyzer platf

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Physician's request to determine bile acids in stool

Exclusion criteria

Exclusion criteria: Hospitalization

Design outcomes

Primary

Measure	Time frame
Quantitative measurements through the Total Bile Acids FS reagent on clinical chemistry analyzers and determination of the recovery and the accuracy against LC-MS/MS referenced liquid individual Bile Acids Standards	—

Secondary

Measure	Time frame
not defined	—

Countries

Germany

Contacts

Public ContactMatthias Grimmler

DiaSys Diagnostic Systems GmbH

matthias.grimmler@diasys.de+49 6432 9146 486

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026